Navigation Links
JumpStart Invests in ABSMaterials and MAX Endoscopy
Date:12/30/2009

CLEVELAND, Dec. 30 /PRNewswire/ -- JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, announces two JumpStart Ventures investments. Absorbent Materials Company LLC (dba ABSMaterials LLC), a company developing a novel, silica-based material that absorbs toxins in water, and MAX Endoscopy Inc., a medical device manufacturer using fiber optics to guide the treatment of hemorrhoids, each received investment commitments of $250,000.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060209/CLJUMPSTARTLOGO )

ABSMaterials' patented "swelling glass," developed by Dr. Paul Edmiston from the College of Wooster, is similar to a highly tensioned, nano-matrix of glass. When it comes in contact with a volatile organic compound in water, such as fuel oils, chlorinated solvents, and hexamine, the glass absorbs the volatile molecules within the compound without reacting with the water. ABSMaterials is currently marketing three variations of the material to firms and government agencies contracted to clean up or remediate toxic groundwater contamination sites.

"We are excited to work with JumpStart Ventures as we continue to prove consistent remediation success with our material," said ABSMaterials Chief Executive Officer, Stephen Spoonamore.

MAX Endoscopy's patent-pending device, called the PRECISION Endoscopic Infrared Coagulator(TM), utilizes infrared light (which coagulates blood vessels) using flexible fiber optic technology. When used in a scope, the result is increased accuracy and visual confirmation of successful treatment. MAX Endoscopy has received FDA clearance on the system and is currently selling to gastroenterologists and colorectal surgeons.

"With this investment, we are beginning to lay the foundation for scalable penetration into the large, profitable, and growing gastrointestinal endoscopy market," said Robert Stuba, President and CEO of MAX Endoscopy.

With these two investments, JumpStart Ventures has invested in four new companies in 2009's fourth quarter, bringing its portfolio of high growth, early-stage companies to 44.

About Absorbent Materials Company LLC

Absorbent Materials Company LLC (www.absmaterials.com) develops reactive glass products and nanosands for remediation or site-cleanups of volatile organic and related spills, plumes or gas discharge. Absorbent Materials' (ABSMaterials) products are engineered to be fully reversible, highly stable, hydrophobic, and capable of capturing and recovering a range of hydrocarbons and pervasive solvents.

About MAX Endoscopy, Inc.

MAX Endoscopy Inc., (www.maxendoscopy.com) headquartered near Cleveland, designs, manufactures and markets innovative endoscopic accessory devices in the field of gastrointestinal (GI) endoscopy. The keystone of its strategy is to provide devices that fill unmet needs in the field of gastroenterology and related medical specialties, and to do it in a way that is novel yet practical and cost-effective. The Company's PRECISION Endoscopic Infrared Coagulator(TM) device is a patent pending, FDA cleared and CE marked endoscopic infrared coagulation device will provide gastroenterologists, surgeons and other physicians with an attractive new option for treating common gastrointestinal conditions such as hemorrhoids, bleeding polypectomy sites, radiation proctitis, colitis, watermelon stomach, dysplasia, gastric ulcers, and Barrett's esophagus. Numerous other potential applications exist in the treatment of small bleeding lesions and vascular malformations encountered in gastroenterology, urology, gynecology, pulmonology, and orthopedics.

About JumpStart Inc.

JumpStart (www.jumpstartinc.org) is a nationally recognized venture development organization that accelerates the progress of high potential, early-stage businesses and includes a special focus on diverse entrepreneurs working in the highest growth industries. Through the depth of its entrepreneurial team and the breadth of its high value resources, JumpStart improves client success in achieving significant milestones, including raising the follow-on capital necessary to create wealth. JumpStart strives to create a more prosperous future for Northeast Ohio.


    Contact Information:
    --------------------
    Cathy Belk, Chief Marketing Officer
    -----------------------------------
    JumpStart Inc.
    --------------
    216.363.3417
    ------------
    cathy.belk@jumpstartinc.org
    ---------------------------

SOURCE JumpStart, Inc.


'/>"/>
SOURCE JumpStart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jumpstart Medicine Opens Two New Locations in San Francisco
2. Scientists discover way to jumpstart bones healing process
3. JumpStart and Case Technology Ventures Invest in Neuros Medical
4. Miami-Dade and Monroe County Organizations Receive Grants to JumpStart the Conversation
5. Freedom Meditech Receives JumpStart Investment
6. CerviLenz Receives JumpStart Investment
7. Aria Analytics Receives JumpStart Investment
8. LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer
9. Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.
10. CVS Caremark Charitable Trust Invests $300,000 in Easter Seals' Autism Services for Young Children
11. ValueOptions(R) Reinvests $3.1 Million in New Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... RICHEY, Fla. (PRWEB) , ... April 24, 2017 ... ... and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives of ... slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
Breaking Medicine Technology: